Preeclampsia is characterized by new-onset of hypertension and proteinuria after 20 weeks of gestation. It affects 2-8% of all pregnancies and is associated with both maternal and perinatal morbidity and mortality. 1,2 The disorder is heterogeneous and a difference in molecular basis between early-onset and late-onset preeclampsia has been discussed. 3 Early-onset preeclampsia comprises between 5 and 20% of all cases and is associated with more severe complications for the mother and the fetus than late-onset preeclampsia. 4 The pathogenesis of preeclampsia is not fully understood but current research focuses on a two-step model. 5 The first step involves an inappropriate trophoblast invasion of the maternal spiral arteries in early pregnancy, which leads to inadequate implantation and placentation, thus causing relative hypoxia in the placenta.
Preeclampsia is characterized by new-onset of hypertension and proteinuria after 20 weeks of gestation. It affects 2-8% of all pregnancies and is associated with both maternal and perinatal morbidity and mortality. 1, 2 The disorder is heterogeneous and a difference in molecular basis between early-onset and late-onset preeclampsia has been discussed. 3 Early-onset preeclampsia comprises between 5 and 20% of all cases and is associated with more severe complications for the mother and the fetus than late-onset preeclampsia. 4 The pathogenesis of preeclampsia is not fully understood but current research focuses on a two-step model. 5 The first step involves an inappropriate trophoblast invasion of the maternal spiral arteries in early pregnancy, which leads to inadequate implantation and placentation, thus causing relative hypoxia in the placenta.
The second step is characterized by a general systemic inflammatory response in which endothelial cell dysfunction is of major relevance. A number of circulating factors contributing to maternal endothelial cell dysfunction have been identified, including syncytiotrophoblast microparticles, cytokines, apoptotic factors, and antiangiogenic as well as proangiogenic factors. Furthermore, endothelial cell dysfunction results in increased coagulability in the placental microvasculature and in the vasculature in general, leading to disturbances of the coagulation as well as the fibrinolytic system. 6 Several potential biophysical and biochemical markers have been evaluated and uterine artery Doppler ultrasonography is thus far the best single predictor of preeclampsia. 7 Doppler examination of the uterine arteries is a noninvasive test suggested to reflect trophoblast invasion and development, as 
Background
Preeclampsia is associated with both maternal and perinatal morbidity and mortality. Histidine-rich glycoprotein (HRG) is a protein interacting with angiogenesis, coagulation, and inflammatory responses, processes known to be altered in preeclamptic pregnancies. Significantly lower levels of HRG have been demonstrated as early as in the first trimester in women later developing preeclampsia compared with normal pregnancies. The aim of this study was to investigate whether the combination of HRG and uterine artery doppler ultrasonography can be used as a predictor of preeclampsia.
Methods
A total of 175 women were randomly selected from a case-control study; 86 women had an uncomplicated pregnancy and 89 women later developed preeclampsia. Blood samples and pulsatility index (PI) were obtained from both cases and controls in gestational week 14. results HRG levels were significantly lower in women who developed preterm preeclampsia compared with controls, but not for women developing preeclampsia in general. PI was significantly higher in the preeclampsia group compared with controls, especially in preterm preeclampsia. The combination of HRG and PI revealed a sensitivity of 91% and a specificity of 62% for preterm preeclampsia.
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well as uteroplacental perfusion. 8 However, optimal screening efficacy by Doppler ultrasonography is performed around gestational week 24 which is relatively late in pregnancy. 9 Based on the current knowledge of preeclampsia, it is unlikely that a single marker will predict all variants of the disorder. For this reason ongoing research predominately focuses on screening tests based on a combination of markers. [10] [11] [12] Histidine-rich glycoprotein (HRG) is a multidomain protein involved in hemostasis as well as in the angiogenic pathway, and has both proangiogenic and antiangiogenic properties. [13] [14] [15] HRG is present at high concentrations in plasma; it is synthesized by parenchymal liver cells and transported as a free protein but can also be stored in α-granules of platelets and released after thrombin stimulation. 16 We have previously shown that HRG is involved in the hypercoagulability and the angiogenic imbalance seen in early-onset preeclampsia. 17 Significantly lower plasma levels of HRG have been demonstrated as early as the first trimester in women who later developed preeclampsia. 18 Based on these studies, HRG has a potential as a first-trimester marker of preeclampsia.
The aim of this study was to investigate whether the combination of HRG and uterine artery Doppler ultrasonography in early pregnancy can be used as a predictor of preeclampsia.
Methods
Study population and demographics. This study was designed as a case-control study. Approval was obtained for the study from the local Research Ethics Committee at Wandsworth, UK, and all women gave written, informed consent before inclusion. The patients were recruited between 2002 and 2005 as part of an ongoing prospective study of Doppler ultrasound and serum markers for preeclampsia in women attending a routine antenatal care visit at St George's Hospital Obstetric Unit, London, UK. Multiparas with a high-risk profile such as essential hypertension, previous pregnancy with preeclampsia or intrauterine growth restriction and all primiparas were included. Pregnancy outcomes were obtained from the delivery suite database or from general practitioners.
In the initial study design done at St George's Hospital Obstetric Unit, preeclampsia was subdivided into term and preterm preeclampsia and in analogy with that the same definition and as well as inclusion criteria were used in our study. Women with preeclampsia who were delivered in gestational week 37 or later were defined as term preeclampsia and women who were delivered before 37 weeks of gestational age were defined as preterm preeclampsia.
A total of 175 women were randomly selected from the cohort: 86 women with an uncomplicated pregnancy (controls) and 89 women who developed preeclampsia (cases).
Preeclampsia was defined according to the International Society for the Study of Hypertension in Pregnancy (ISSHP), as two recordings of diastolic blood pressure of 140/90 mm Hg or greater at least 4 h apart in previously normotensive women and proteinuria of 300 mg or more in 24 h, or two readings of at least two on dipstick analysis of midstream or catheter urine specimens if a 24-h collection was not available, and developed after 20 weeks of gestation.
Patient characteristics including demographics, smoking status, and obstetric and medical history were obtained from women at the first hospital visit and entered into a fetal medicine unit database.
Sample collection. Maternal blood was collected in nonheparinized tubes, allowed to clot, and centrifuged. Serum was transferred to new tubes (Eppendorf, Hamburg, Germany). The blood samples were on average collected at gestational week 14, where the mean day at sampling was 5 days later in women who developed preeclampsia than controls. The samples were stored at −80 °C and the mean storage time before analysis was 8 years, with only one freeze thaw-cycle for allocation of sample aliquots. The samples were transported from Britain to Sweden with carbon dioxide ice and remained frozen upon arrival.
Doppler ultrasound. As part of routine antenatal scans, uterine artery pulsatility index (PI) was abdominally measured in the first or second trimester of those women who gave their permission. The ultrasound probe was held in the sagittal axis and moved laterally. B-mode ultrasound examination was used to visualize the vessels lateral to the uterus, and color Doppler was used to identify the uterine artery at the apparent crossover with the external iliac artery. A pulsed-wave Doppler gate was then placed over the uterine artery with an angle of insonation less than 60 °. When three similar consecutive waveforms were obtained, the presence of a protodiastolic notch was recorded, the PI was measured, and the mean was calculated. Ultrasound scans were performed only by trained ultrasonographers or fetal medicine specialists. The ultrasound examination was on average performed at gestational week 14+6 and in 159 of the 175 women Doppler indexes were registered.
The uterine artery PI was expressed as multiples of the median (MoM) to correct for changes in the normal values with gestational age.
ELISA. The wells of a PVC micro titer plate (F96 Maxisorp, cat. no. 106171; Nunc, Roskilde, Denmark) were coated with a polyclonal HRG capture antibody (H00003273-B01P; AbNova, Walnut, CA) in a bicarbonate buffer, pH 9.6, for 1 h at 37 °C, followed by two washing steps using phosphate-buffered saline. Blocking buffer containing 0.05% bovine serum albumin was added for 1 h at room temperature, followed by two more washing steps using phosphate-buffered saline. The samples were incubated for 45 min at room temperature and then washed four times. For detection, a second antibody (HRG-0119; Lena Claesson-Welsh, Department of Immunology, Genetics and Pathology, and Anna-Karin Olsson, Department of Medical Biochemistry and Microbiology, Uppsala Biomedical Center both from Uppsala University, Uppsala, Sweden), was added for 1 h at room temperature, then followed by four steps of washing. Incubation with a biotinylated anti-rabbit IgG antibody (BA-1000; Vector Laboratories, Burlingame, CA) was original contributions HRG and Ultrasound for Prediction of Preeclampsia performed, washed, and then streptavidin-conjugated horseradish peroxidase in phosphate-buffered saline/0.1% Tween was added. Levels of HRG were analyzed at the optical density of 450 nm after adding a TMB (3,3′,5,5′-tetramethylbenzidine) containing substrate and stopping solution (2 mol/l H 2 SO 4 ). A standard curve of purified human HRG was included in each trial. Both the intra-and inter-assay variations were 7.7%. Table 1 
Statistical analysis. Background variables in
are presented as mean values ± s.d. Comparisons between different continuous variables were made with Student's t-test and a χ 2 test was used for proportions. Non-normally distributed variables were compared by Mann-Whitney U-test. A receiver operator characteristic curve was constructed to determine the best cut-off values of HRG and PI for prediction of preeclampsia. Two tailed P values <0.05 were considered as statistically significant. All statistical analyses were performed by SPSS 18.0 for Windows software pack (SPSS, Chicago, IL).
results

Background characteristics
Maternal characteristics and pregnancy outcome of cases and controls are presented in Table 1 . Women who developed preeclampsia did not differ from controls in terms of maternal age or smoking habits at enrolment, but had higher body mass index and were less often nulliparous. Gestational age at delivery was significantly shorter in the group who developed preeclampsia; in this group 62 women were defined as term preeclampsia and 27 women were defined as preterm preeclampsia. All controls were delivered at term. As expected, women with preeclampsia delivered infants with lower birth weights.
serum levels of hrg and uterine artery doppler
Women who developed preterm preeclampsia had significantly lower levels of HRG compared with controls (45.0 vs. 82.7 μg/ ml, P = 0.001). However, for the entire group of women who developed preeclampsia, no difference in comparison with controls was found (80.2 vs. 82.7 μg/ml, Table 2, Figure 1 ).
HRG levels were tested for correlation to gestational age using the Pearson correlation test but no correlation was observed (P = 0.2, r = −0.1). PI, expressed as MoM (PI MoM), was significantly higher in the preeclampsia group, especially among women who developed preterm preeclampsia (1.1 vs. 1.0, P < 0.05 and 1.6 vs. 1.0, P < 0.001, Table 2, Figure 1 ).
cut-off value for prediction of preeclampsia
Receiver operator characteristic curves for HRG, PI MoM, and a combination of HRG and PI MoM were constructed. original contributions
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Sensitivities at different specificity levels for prediction of preterm preeclampsia were obtained (Figure 2, Table 3 ). The area under the curve was 0.72 (95% confidence interval, 0.61-0.83; P = 0.001) for HRG, 0.79 (95% confidence interval, 0.67-0.90; P < 0.001) for PI MoM, and 0.85 (95% confidence interval 0.77-0.93; P < 0.001) for the combination of HRG and PI MoM (Figure 2) .
For prediction of preterm preeclampsia, a suggested optimal cut-off value for HRG <67.8 μg/ml had a sensitivity of 74% and a specificity of 66%, whereas a cut-off value for PI MoM >1.3 had a sensitivity of 78% and a specificity of 81%. The highest values for prediction were found using the combination of HRG and PI MoM with a sensitivity of 91% and a specificity of 62%. As an alternative to the optimal cut-off value, the predictive value of the combination of HRG and PI MoM could be presented as a detection rate of 39% and 61% at a false-positive rate of 5 and 10%, respectively.
discussion
In previous studies, we have found a possible association between HRG and preeclampsia. 17, 18 Furthermore, we have suggested that HRG has the potential as a first-trimester biomarker for prediction of preeclampsia. 18 In this study, we have shown that separate measurements of HRG and PI may predict preterm preeclampsia but by combining HRG and PI the accuracy increased. Our results are in line with studies proposing a combination of biochemical and biophysical markers for a successful prediction of preeclampsia in early pregnancy. 11, 12 Several biological processes are associated with preeclampsia; these include the imbalance between angiogenesis and antiangiogenesis, 19 the excessive inflammatory response, 20 and the hypercoagulability seen in general, but especially in the placenta. 21, 22 HRG is a protein known to interact with all these processes. [13] [14] [15] 23 The exact mechanism of HRG and its relevance in preeclampsia remains to be elucidated. HRG has been reported to have both proantiangiogenic and antiangiogenic properties. It has been suggested that the antiangiogenic effect of HRG is mediated partly via signal transduction targeting focal adhesions and thereby interrupting vascular endothelial growth factor-induced endothelial cell motility. 24, 25 The proangiogenic effect might be a result of inhibition of the antiangiogenic effect mediated through interaction with trombospondin. 26 HRG has also been shown to act as a negative acute phase reactant 23, 27 and in response to tissue injury plasma levels of HRG are consequently reduced.
Preeclampsia is also characterized by increased vascular coagulability which is particularly pronounced in the placental microvasculature where it is associated with disturbances of both the coagulation and the fibrinolytic system. 28 HRG is known to interact with fibrinogen and these proteins are recognized as key regulators of the coagulation system. 27 HRG has furthermore been shown to be incorporated in fibrin clots, 29 a process that decreases the amount of free HRG in plasma and which has been speculated to be associated with the microthrombi seen in placentas from women with preeclampsia. 17 HRG is transported mainly in platelets and released in response to the stimuli to which the platelets are exposed. 30 In preeclampsia, but to a smaller degree also in normal pregnancy, the platelet degranulation response is enhanced. 31 The generally activated endothelium seen in preeclampsia may thus stimulate the release of these hyperreactive granules, which in turn leads to increased clot formation and platelet adhesion to the vascular wall.
Identification of women with increased risk of preeclampsia at an early gestational age is important. 32 Doppler examination of the uterine arteries can be used to visualize suspected pathology in the uteroplacental circulation and different Doppler indexes as single markers of preeclampsia have been evaluated. 33, 34 However, in previous studies, the presence of early bilateral notches on the Doppler waveform cannot be used as an early predictor of preeclampsia, due to the high prevalence of this finding in normal pregnancies too. 35 In our study, we found a fairly good association between presence of notches and preeclampsia (data not shown) but in accordance with previous studies, we decided to use PI as the Doppler index and single ultrasonography marker.
Early-onset preeclampsia has been proposed to have a stronger association with inadequate and incomplete original contributions
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trophoblast invasion and spiral artery remodeling than lateonset preeclampsia. 4, 5 It has been hypothesized that earlyonset preeclampsia has a placental origin, whereas late-onset preeclampsia may be more dependent on the maternal constitution. In a previous study, we found an association between placental HRG and early-onset preeclampsia 17 whereas in this study, we present an association between HRG plasma level and preterm, but not term, preeclampsia. Both uterine artery Doppler and HRG concentration may reflect the impaired trophoblast invasion, known to be more pronounced in early-onset preeclampsia. A combination of these tests in early pregnancy might therefore reflect impaired placentation better than each individual test alone. This theory is supported by the finding of higher accuracy when these tests are combined instead of used separately.
The major strength of this study is the potential for early detection of those at risk of developing preterm preeclampsia and the main purpose of an early predictive test would be to detect women who will develop preeclampsia early in pregnancy, when it would be possible to achieve medical intervention, optimized antenatal surveillance, early diagnosis, and timely delivery. 32 A clinically useful predictor of preeclampsia has high sensitivity as well as high specificity. Unfortunately such tests are rare in clinical practice and we therefore have to prioritize. 32 We believe that the consequences of a false-negative test result may do more harm than a false-positive test result, even if the latter causes increased concern and anxiety for the women. Accordingly, we have chosen cut-off values out of the receiver operator characteristic curves, resulting in high sensitivity and somewhat lower specificity.
One limitation with our study is that all women included are from a high-risk population with significant differences in parity and body mass index between women with normal pregnancies and women developing preeclampsia. However, HRG levels were not associated to either body mass index or parity. There are also a relatively limited number of women who develop preterm preeclampsia. Further studies are needed to confirm our results and the use of additional potential biochemical markers, together with HRG and Doppler ultrasonography, might further improve the predictive values.
In conclusion, we have shown that the combination of HRG and uterine artery Doppler in early pregnancy may be a predictor of preterm preeclampsia.
